Clinical Trial Update: Adjuvanting Viral Vectored Malaria Vaccines With Matrix M [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Matrix-M adjuvant with Oxford viral-vectored malaria vaccines (ChAd63-MVA ME-TRAP); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAd63-MVA ME-TRAP (ChAd63-MVA ME-TRAP viral vectored malaria vaccine)
• Matrix-M (Matrix-M adjuvant)

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Matrix M | Phase 1 | Status: COMPLETED